Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

mdm2 mRNA level is a prognostic factor in soft tissue sarcoma.

Molecular medicine (Cambridge, Mass.) - 1 Jan 2000

Taubert H, Koehler T, Meye A, Bartel F, Lautenschläger C, Borchert S, Bache M, Schmidt H, Würl P

Abstract excerpt

BACKGROUND: The oncogenic properties of murine double minute-2 (mdm2) protein over-expression, which mostly results from the interaction with the tumor suppressor p53, are well described and their negative impacts on the prognosis of affected patients is well characterized. However, clinical relevance of mdm2 mRNA expression is poorly investigated. MATERIALS AND METHODS: In this study, 65 soft tissue sarcoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multivariate Analysis
Share to Neoplasm Staging
Share to Nuclear Proteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins c-mdm2

Share to RNA, Neoplasm

Share to Sarcoma

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 10803408
PMCID: PMC1949909

Genes

STS
GAPDH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

mdm2 mRNA level is a prognostic factor in soft tissue sarcoma.PMID 10803408Read ↗

Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma.Semantic proximity Read ↗

MDM2 Gene Amplification and Transcript Levels in Human Sarcomas: Relationship to TP53 Gene StatusSemantic proximity Read ↗

MDM2 inhibitors in sarcomas: results and next stepsSemantic proximity Read ↗

The Role of MDM2 Amplification and Overexpression in Tumorigenesis.Semantic proximity Read ↗

Significance of retinoblastoma and mdm2 gene expression as prognostic markers for soft-tissue sarcoma.Semantic proximity Read ↗

[Frequency, distribution and prognostic relevance of p53 mutations in soft tissue sarcomas].Semantic proximity Read ↗

Association of HDM2 transcript levels with age of onset and prognosis in soft tissue sarcomas.Semantic proximity Read ↗

The MDM2 gene amplification databaseSemantic proximity Read ↗

The human MDM-2 oncogene is overexpressed in leukemiasSemantic proximity Read ↗

Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma.Semantic proximity Read ↗

[HDMX amplification and high levels of HDMX-S splice variant are correlated with a poor prognosis in soft tissue sarcomas].Semantic proximity Read ↗

MDM2 and PrognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.